| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |